1. Home
  2. Companies
  3. Vertex Pharmaceuticals Incorporated
  4. Financial Ratios
  5. Cash Conversion Cycle
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
$ 445.77 0.63%

Quarterly report 2026-Q1
added 05-05-2026

report update icon

Vertex Pharmaceuticals Incorporated Cash Conversion Cycle 2011-2026 | VRTX

Annual Cash Conversion Cycle Vertex Pharmaceuticals Incorporated

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
279 192 132 106 106 95.6 109 69 107 71.8 14.9 -185 -72.8 -58.1 219

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
279 -185 78.9

Quarterly Cash Conversion Cycle Vertex Pharmaceuticals Incorporated

2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
353 - 306 278 271 - 204 188 168 - 136 124 120 - 68.3 55.7 113 - 124 122 120 106 114 115 103 80.3 116 115 100 52.9 58.6 61.4 81.8 80.5 91.8 95.7 83.2 39.9 44.3 42.5 43 38 51.8 97.6 83.5 48 38.7 50.1 62.2 22.2 35.2 25.1 31.8 39.1 38.9 31.2 33.9 29.7 25.4 146 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
353 22.2 96.4

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		3.11 K - 5743.5 % $ 69.7 M canadaCanada
Compugen Ltd. Compugen Ltd.
CGEN
 		-82.7 $ 2.02 -0.98 % $ 189 M israelIsrael
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		-3.12 K - 1.35 % $ 17.8 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
 		149 $ 1.42 - $ 166 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		-1.97 K - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		-101 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		12.8 - - $ 40.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		1.73 - - $ 2.17 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
 		-58 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		17 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		82.8 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		31.4 - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		1.1 K $ 51.48 -0.23 % $ 4.63 B schweizSchweiz
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
 		-55.7 K - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		214 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		-3.74 K $ 29.6 3.64 % $ 1.97 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		47.6 - - $ 344 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		-2.15 K - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		-1.6 K - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
 		192 $ 14.57 -0.21 % $ 209 M usaUSA
Advaxis Advaxis
ADXS
 		-82.3 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		-34.3 K - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		-1.92 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		-1.55 K - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		158 $ 22.79 5.8 % $ 2.9 B usaUSA